IPP Bureau
Syngene collaborates with Johns Hopkins University to advance early-stage drug discovery
By IPP Bureau - February 11, 2026
The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
Wockhardt reports strong Q3 growth: revenue up 22%, EBITDA surges 72%
By IPP Bureau - February 11, 2026
The company reported profit before tax of Rs.67 crore, up sharply from Rs.21 crore in the same period last year
Apollo Hospitals reports robust Q3 earnings; profit after tax humps to Rs. 3,835 million
By IPP Bureau - February 11, 2026
Revenue from operations rose to Rs. 23,637 million for the three months ended December 31, 2025
Iambic taps AI to power multi-year drug discovery deal with Takeda
By IPP Bureau - February 11, 2026
Veradermics completes enrollment in both Phase 3 male hair loss trials
By IPP Bureau - February 11, 2026
The milestone means more than 1,000 men are now enrolled across both Phase 3 programs
Lilly to acquire Orna Therapeutics in deal valued at up to $2.4 billion
By IPP Bureau - February 10, 2026
The acquisition brings Lilly a novel in vivo cell therapy platform built around engineered circular RNA and proprietary lipid nanoparticles
Motorica showcases advanced prosthetics expertise at OPAI National Conference
By IPP Bureau - February 10, 2026
Motorica India conducted a specialised masterclass led by Shumaev, centred on real-life rehabilitation scenarios and personalised therapy programs before and after prosthetic fitting
India’s go-to diabetes test under scrutiny as new evidence flags major gaps
By IPP Bureau - February 10, 2026
The paper highlights how conditions common across India—including anemia, inherited hemoglobin disorders, and glucose-6-phosphate dehydrogenase (G6PD) deficiency—can significantly distort HbA1c readings
Roche BTK drug emerges as potential breakthrough in primary progressive MS
By IPP Bureau - February 10, 2026
Antara Senior Care launches second Chennai care home amid growing senior population
By IPP Bureau - February 10, 2026
The new OMR facility, located in Chennai’s medical hub, is close to leading hospitals and offers excellent road and air connectivity
Ajooni Biotech bags record Rs. 47.52 crore order
By IPP Bureau - February 10, 2026
The company has commissioned a new plant at Khanna (Punjab), which has begun commercial production
Entero Healthcare expands MedTech footprint with acquisition of Anand Chemiceutics
By IPP Bureau - February 10, 2026
Anand Chemiceutics serves over 1,500 laboratories, hospitals, and government institutions
Zydus Lifesciences reports strong Q3 & 9M FY26 growth
By IPP Bureau - February 10, 2026
Revenue from operations surged 30% year-on-year to Rs. 68,645 million
GSK India crosses Rs. 1,000 crore mark, key portfolios drive 8.1% topline growth
By IPP Bureau - February 10, 2026
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
Neuland Laboratories reports Rs 1,264.5 crore revenue for 9MFY26
By IPP Bureau - February 10, 2026
The revenues this quarter are in line with the outlook we envisaged for the year
